Demir Y, Ceylan H, Türkeş C, Beydemir Ş. Molecular docking and inhibition studies of vulpinic, carnosic and usnic acids on polyol pathway enzymes. J Biomol Struct Dyn. 2022;40(22):12008–21.

Article  CAS  PubMed  Google Scholar 

Sever B, Altıntop MD, Demir Y, et al. Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds. Bioorg Chem. 2020;102:104110.

Article  CAS  PubMed  Google Scholar 

Bellary S, Kyrou I, Brown JE, Bailey CJ. Type 2 diabetes mellitus in older adults: clinical considerations and management. Nat Rev Endocrinol. 2021;17(9):534–48.

Article  PubMed  Google Scholar 

Hu Q, Chen Y, Deng X, et al. Diabetic nephropathy: focusing on pathological signals, clinical treatment, and dietary regulation. Biomed Pharmacother. 2023;159:114252.

Article  PubMed  Google Scholar 

Sharma D, Bhattacharya P, Kalia K, Tiwari V. Diabetic nephropathy: new insights into established therapeutic paradigms and novel molecular targets. Diabetes Res Clin Pract. 2017;128:91–108.

Article  CAS  PubMed  Google Scholar 

Kato M, Natarajan R. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory. Nat Rev Nephrol. 2019;15(6):327–45.

Article  PubMed  PubMed Central  Google Scholar 

Sever B, Altıntop MD, Demir Y, et al. Identification of a new class of potent aldose reductase inhibitors: design, microwave-assisted synthesis, in vitro and in silico evaluation of 2-pyrazolines. Chem Biol Interact. 2021;345: 109576.

Article  CAS  PubMed  Google Scholar 

Sever B, Altıntop MD, Demir Y, et al. An extensive research on aldose reductase inhibitory effects of new 4H-1,2,4-triazole derivatives. J Mol Struct. 2021;1224:129446.

Article  CAS  Google Scholar 

Warren AM, Knudsen ST, Cooper ME. Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies. Expert Opin Therap Targ. 2019;23(7):579–91.

Article  Google Scholar 

Liu L, Bai F, Song H, et al. Upregulation of TIPE1 in tubular epithelial cell aggravates diabetic nephropathy by disrupting PHB2 mediated mitophagy. Redox Biol. 2022;50:102260.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Türkeş C, Arslan M, Demir Y, et al. N-substituted phthalazine sulfonamide derivatives as non-classical aldose reductase inhibitors. J Mol Recog. 2022;35(12):e2991.

Article  Google Scholar 

Akdağ M, Özçelik AB, Demir Y, Beydemir Ş. Design, synthesis, and aldose reductase inhibitory effect of some novel carboxylic acid derivatives bearing 2-substituted-6-aryloxo-pyridazinone moiety. J Mol Struct. 2022;1258:132675.

Article  Google Scholar 

Jefferson JA, Shankland SJ, Pichler RH. Proteinuria in diabetic kidney disease: a mechanistic viewpoint. Kidney Int. 2008;74:22–36.

Article  CAS  PubMed  Google Scholar 

de Zeeuw D, Renfurm RW, Bakris G, et al. Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial. Lancet Diabetes Endocrinol. 2018;6:925–33.

Article  PubMed  Google Scholar 

Mima A, Arai H, Matsubara T, et al. Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy. Diabetes. 2008;57(6):1712–22.

Article  CAS  PubMed  Google Scholar 

Doi T, Mima A, Matsubara T, Tominaga T, Arai H, Abe H. The current clinical problems for early phase of diabetic nephropathy and approach for pathogenesis of diabetic nephropathy. Diabetes Res Clin Pract. 2008;82(Suppl 1):21–4.

Article  Google Scholar 

Rossing P, Anker SD, Filippatos G, et al. Finerenone in patients with chronic kidney disease and type 2 diabetes by sodium-glucose cotransporter 2 inhibitor treatment: the FIDELITY Analysis. Diabetes Care. 2022;45(12):2991–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sharma D, Verma S, Vaidya S, Kalia K, Tiwari V. Recent updates on GLP-1 agonists: current advancements & challenges. Biomed Pharmacother. 2018;108:952–62.

Article  CAS  PubMed  Google Scholar 

Barde YA, Lindsay RM, Monard D, Thoenen H. New factor released by cultured glioma cells supporting survival and growth of sensory neurones. Nature. 1978;274:818.

Article  CAS  PubMed  Google Scholar 

Guenther J, Nick H, Monard D. A glia-derived neurite-promoting factor with protease inhibitory activity. EMBO J. 1985;4:1963–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stone SR, Nick H, Hofsteenge J, Monard D. Glial-derived neurite-promoting factor is a slow-binding inhibitor of trypsin, thrombin and urokinase. Arch Biochem Biophys. 1987;252:237–44.

Article  CAS  PubMed  Google Scholar 

Mansilla S, Boulaftali Y, Venisse L, et al. Macrophages and platelets are the major source of protease nexin-1 in human atherosclerotic plaque. Arterioscler Thromb Vasc Biol. 2008;28:1844–50.

Article  CAS  PubMed  Google Scholar 

Fayard B, Bianchi F, Dey J, et al. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression. Cancer Res. 2009;69:5690–8.

Article  CAS  PubMed  Google Scholar 

Rosenblatt DE, Cotman CW, Nieto-Sampedro M, Rowe JW, Knauer DJ. Identification of a protease inhibitor produced by astrocytes that is structurally and functionally homologous to human protease nexin-I. Brain Res. 1987;415:40–8.

Article  CAS  PubMed  Google Scholar 

McKee CM, Ding Y, Zhou J, et al. Protease nexin 1 induces apoptosis of prostate tumor cells through inhibition of X-chromosome-linked inhibitor of apoptosis protein. Oncotarget. 2015;6:3784–96.

Article  PubMed  PubMed Central  Google Scholar 

Santoro A, Conde J, Scotece M, et al. SERPINE2 inhibits IL-1α-induced MMP-13 expression in human chondrocytes: involvement of ERK/NF-κB/AP-1 pathways. PLoS ONE. 2015;10:e0135979.

Article  PubMed  PubMed Central  Google Scholar 

Geiger M, Wahlmüller F, Furtmüller M, In: Geiger M, editor. The Serpin family: proteins with multiple functions in health and disease. Cham: Springer. 2015. pp. 179–89.

Monard D. SERPINE2/Protease Nexin-1 in vivo multiple functions: does the puzzle make sense? Semin Cell Dev Biol. 2017;62:160–9.

Article  CAS  PubMed  Google Scholar 

Zhang J, Huang F, Gong T, Liu Z. SERPINE2 promotes esophageal squamous cell carcinoma metastasis by activating BMP4. Cancer Lett. 2020;469:390–8.

Article  CAS  PubMed  Google Scholar 

Wang K, Wang B, Xing AY, et al. Prognostic significance of SERPINE2 in gastric cancer and its biological function in SGC7901 cells. J Cancer Res Clin Oncol. 2015;141:805–12.

Article  CAS  PubMed  Google Scholar 

Yang Y, Xin X, Fu X, Xu D. Expression pattern of human SERPINE2 in a variety of human tumors. Oncol Lett. 2018;15:4523–30.

PubMed  PubMed Central  Google Scholar 

Smirnov DA, Morley M, Shin E, Spielman RS, Cheung VG. Genetic analysis of radiation-induced changes in human gene expression. Nature. 2009;459:587–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hao F, Zhang S. Correlation between serum IL-22 and IL-27 levels and vasculopathy in diabetic nephropathy patients. Am J Transl Res. 2024;16:5659–66.

Article  PubMed  PubMed Central